This brand name is authorized in New Zealand
The drug JESPECT contains one active pharmaceutical ingredient (API):
|
1
Japanese encephalitis, live attenuated
UNII ZZ1CP75F3U - JAPANESE ENCEPHALITIS LIVE ATTENUATED STRAIN SA 14-14-2 ANTIGEN
|
|
Japanese encephalitis is a disease caused by the mosquito-borne Japanese encephalitis virus (JEV). Japanese Encephalitis Vaccine acts by inducing antibodies that neutralize live JEV. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BA02 | Encephalitis, Japanese, inactivated, whole virus | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BA Encephalitis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 15410 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
